PDCD1LG2 (N-term), 46-75 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-PDCD1LG2 (N-term), 46-75 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | PDCD1LG2 (N-term), 46-75 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.38 |
| Applications | Western Blot (WB), ELISA (EIA), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This PDCD1LG2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 46-75 amino acids from the N-terminal region of human PDCD1LG2. PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production (By similarity). |
| Immunogen | n/a |
| Other Names | [Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; B7-DC; CD273; PDCD1LG2; B7DC; CD273; PDCD1L2; PDL2] |
| Gene, Accession # | [PDCD1LG2], Gene ID: 80380, NCBI: NP_079515.2, UniProt: Q9BQ51 |
| Catalog # | MBS9202016 |
| Price | $165, $370 |
| Order / More Info | PDCD1LG2 (N-term), 46-75 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Ellis, J.S., et al. J. Immunol. 185(6):3149-3157(2010) Pena-Cruz, V., et al. J. Invest. Dermatol. 130(9):2222-2230(2010) Ghiotto, M., et al. Int. Immunol. 22(8):651-660(2010) Ishizaki, Y., et al. Hum. Genet. (2010) In press : Kassel, R., et al. Hepatology 50(5):1625-1637(2009) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies